GlobeNewsWire
24 Jun 2026, 18:50 UTC · 12w ago
Verdict
Headline leans bearish. We score ADMA −1.00 across three claims.
Score confirms the headline.
Leans bearish
From its wording — no explicit rating
−1.00strongly bearish
What the story claims
3 claims · scored −1 bearish … +1 bullish
ADMA Biologics is facing a class action lawsuit alleging securities fraud, including the use of channel stuffing to inflate revenues and undisclosed related party transactions.
So whatAllegations of financial manipulation and internal control failures are fundamental risks to a company's valuation and credibility.
More negative than 98% of claims this week
Culper Research reported that ADMA's reported 20% growth in 2025 was actually a 3% decline when adjusting for payment terms and channel stuffing.
So whatA direct contradiction of growth narratives usually leads to significant valuation write-downs and investor exodus.
Continue reading
5 related stories
More negative than 96% of ticker scores this week
Scored by the NIS engine · methodology.
Search tags
More negative than 96% of claims this week
Cantor Fitzgerald downgraded ADMA Biologics from Overweight to Neutral following concerns over the Culper Research short report.
More negative than 86% of claims this week
Which stocks this story touches
More negative than 96% of ticker scores this week
The company is facing a class action lawsuit alleging securities fraud, channel stuffing, and internal control failures.
More negative than 88% of ticker scores this week
Mentioned at the end of the article as being subject to a case alleging false or misleading statements to investors.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
1h ago
+3.0%
Price is moving against the score
$8.95 vs $8.69 close before publication (Jun 23) · not market-adjusted
ADMA chart →
